Deadline October 31, 2024
The EDL Secretariat is pleased to announce the opening of the public comments period for the applications received for the fifth edition of the WHO Model List of Essential In Vitro Diagnostics (EDL 5) and comments on the tests included in the EDL4. All comments shall be made using the form for public comments and sent to the Secretariat at EDLSecretariat@who.int by October 31, 2024. All EDL5 applications are available here.
The WHO model list of essential in vitro diagnostics (EDL) is a policy document, based on scientific evidence, consisting of a list of categories of IVD tests for infectious diseases and non-communicable diseases and recommendations for its use at different levels of the health care system. The EDL is intended to support IVD policy development to improve people access to IVD testing and clinical laboratory services. Please visit Selection, access and use of in vitro diagnostics for detailed information.
The update of the EDL is a rigorous evidence-based process, the list is updated regularly with periodic calls for submission of applications. The EDL Secretariat oversees submissions, and the Strategic Advisory Group of Experts on IVDs (SAGE IVD) is responsible for reviewing applications and making final recommendations. Before the SAGE IVD meeting, all applications received and the preliminary reviews from the experts are available for public comments through the WHO website.